Consolidated Statements of Operations - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
| Revenue: | ||||||
| Product revenues | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 28,000 |
| License revenues | 0 | 0 | 0 | 27,000 | 27,000 | 33,000 |
| TOTAL NET REVENUE | 0 | 0 | 0 | 27,000 | 27,000 | 61,000 |
| Cost of Product Revenue | 0 | 0 | 0 | 0 | 0 | 57,000 |
| Gross profit | 0 | 0 | 0 | 27,000 | 27,000 | 4,000 |
| Operating Expenses: | ||||||
| Research and development | 250,000 | 225,000 | 725,000 | 475,000 | 1,000,000 | 0 |
| Selling, general and administrative | 2,280,000 | 2,552,000 | 7,827,000 | 5,571,000 | 7,954,000 | 2,400,000 |
| Total operating expenses | 2,530,000 | 2,777,000 | 8,552,000 | 6,046,000 | 8,954,000 | 2,400,000 |
| Loss from Operations | (2,530,000) | (2,777,000) | (8,552,000) | (6,019,000) | (8,927,000) | (2,396,000) |
| Other income (expense) | ||||||
| Change in value of warrant and derivative liabilities | 436,000 | 2,809,000 | 37,195,000 | 20,683,000 | (6,760,000) | (15,963,000) |
| Interest expense/income | (1,536,000) | (1,724,000) | (4,781,000) | (10,012,000) | (17,039,000) | (5,146,000) |
| Total Other Income (Expense) | (1,100,000) | 1,085,000 | 32,414,000 | 10,671,000 | (23,799,000) | (21,109,000) |
| Income (Loss) before minority interest and provision for income taxes | (3,630,000) | (1,692,000) | 23,862,000 | 4,652,000 | (32,726,000) | (23,505,000) |
| Plus: net (income) loss attributable to the noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 16,000 |
| Income (Loss) before provision for income taxes | (3,630,000) | (1,692,000) | 23,862,000 | 4,652,000 | (32,726,000) | (23,489,000) |
| Provision for income taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income (loss) | $ (3,630,000) | $ (1,692,000) | $ 23,862,000 | $ 4,652,000 | $ (32,726,000) | $ (23,489,000) |
| Income/(loss) per share - Basic | $ 0.13 | $ 0.71 | $ 1.05 | $ 1.94 | ||
| Income/(loss) per share - Diluted | $ 0.13 | $ 0.71 | $ 1.05 | $ 0.98 | ||
| Loss Per Share - basic and diluted | $ (13.67) | $ (0.04) | ||||
| Weighted Average Common Shares Outstanding - Basic | 27,462,111 | 2,400,000 | 22,656,666 | 2,392,683 | ||
| Weighted Average Common Shares Outstanding - Diluted | 27,462,111 | 2,400,000 | 22,656,666 | 4,764,753 | ||
| Weighted Average Shares Outstanding - Basic and diluted | 2,394,540 | 2,327,873 | ||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in the income statement of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|